<table id="id_e0a580c9-8c2d-4de7-a76c-e56196340a83" width="474" xmlns="urn:hl7-org:v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<col width="16.3%"></col>
<col width="18.3%"></col>
<col width="19.0%"></col>
<col width="46.3%"></col>
<tbody>
<tr id="id_acc9af47-9f47-4d4c-9393-c62c50858ad2">
<td align="left" colspan="4" valign="top">
<content stylecode="bold">Digoxin concentrations increased greater than 50% </content>
</td>
</tr>
<tr id="id_b5c86835-8bf6-4c44-b79d-4f6c7070b8c4">
<td align="left" valign="top"></td>
<td align="center" valign="top">     Digoxin Serum     <br/>Concentration<br/>Increase</td>
<td align="center" valign="top">     Digoxin AUC     <br/>Increase</td>
<td align="center" valign="top">
<content stylecode="bold">Recommendations</content>
</td>
</tr>
<tr id="id_33467e08-aa43-41b9-a20f-54d33d4ec0d1">
<td align="left" valign="top">Quinidine</td>
<td align="center" valign="top">NA</td>
<td align="center" valign="top">
<paragraph>54-83%</paragraph>
</td>
<td align="left" rowspan="2" valign="top">Measure serum digoxin concentrations before     <br/>initiating concomitant drugs. Reduce digoxin<br/>concentrations by decreasing dose by<br/>approximately 30-50% or by modifying the<br/>dosing frequency and continue monitoring.</td>
</tr>
<tr id="id_1fcbe343-3b95-4023-ad66-8e6ca5b5888c">
<td align="left" valign="top">Ritonavir</td>
<td align="center" valign="top">NA</td>
<td align="center" valign="top">86%</td>
</tr>
<tr id="id_ca9f23f1-ac22-4918-a428-1acee6e893bf">
<td align="left" colspan="4" valign="top">
<content stylecode="bold">Digoxin concentrations increased less than 50%</content>
</td>
</tr>
<tr id="id_ed03e168-f505-48ca-8a7d-667f2656bb40">
<td align="left" valign="top">Amiodarone</td>
<td align="center" valign="top">17%</td>
<td align="center" valign="top">40%</td>
<td align="left" rowspan="5" valign="top">Measure serum digoxin concentrations before initiating concomitant drugs. Reduce digoxin concentrations by decreasing the dose by approximately 15-30% or by modifying the dosing frequency and continue monitoring.</td>
</tr>
<tr id="id_fa3639f8-e2ac-4570-8d21-c5825af2b542">
<td align="left" valign="top">Propafenone</td>
<td align="center" valign="top">28%</td>
<td align="center" valign="top">29%</td>
</tr>
<tr id="id_19379f1d-e969-40ea-ad46-b84b6705dadd">
<td align="left" valign="top">Quinine </td>
<td align="center" valign="top">NA</td>
<td align="center" valign="top">34-38%</td>
</tr>
<tr id="id_de7906f6-e09e-4ca7-a2a0-d52ed460294c">
<td align="left" valign="top">Spironolactone     </td>
<td align="center" valign="top">NA</td>
<td align="center" valign="top">44%</td>
</tr>
<tr id="id_6ec35552-dde9-431f-943f-71a6078fb503">
<td align="left" valign="top">Verapamil</td>
<td align="center" valign="top">NA</td>
<td align="center" valign="top">24%</td>
</tr>
<tr id="id_d55af9f6-9f65-48eb-90a8-036cc939c75c">
<td align="left" colspan="4" valign="top">
<content stylecode="bold">No significant Digoxin exposure changes</content>
</td>
</tr>
<tr id="id_9833abdc-a4e6-470d-92de-a59f6fc6bdce">
<td align="left" colspan="3" stylecode="Botrule" valign="top">Please refer to section 12 for a complete list of drugs<br/>that were studied but reported no significant changes<br/>on digoxin exposure.</td>
<td align="left" stylecode="Botrule" valign="top">No additional actions are required.</td>
</tr>
</tbody>
</table>